Genentech, a member of the Roche Group, today announced it will make its first milestone payment to ForSight VISION4, Inc. as part of an exclusive license agreement to develop the company’s investigational drug delivery device, designed to provide sust…
Day: January 13, 2012
Let Patients See Visit Notes?; also, Medical Device Risks
Important malpractice and legal developments; ongoing cases and other news. Medscape Business of Medicine
Age-Related Blindness May Be Warded Off By Grapes
Can eating grapes slow or help prevent the onset of age-related macular degeneration (AMD), a debilitating condition affecting millions of elderly people worldwide? Results from a new study published in Free Radical Biology and Medicine suggest this mi…
Gene Identified As A New Target For Treatment Of Aggressive Childhood Eye Tumor
St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project findings help solve mystery of retinoblastoma’s rapid growth in work that also yields a new treatment target and possible therapy New findings from the St…
Ocular drug delivery: DSM awarded membership in PANOPTES EU Funded Consortium
DSM, a global leader in biomedical materials sciences, today announced that it is contributing proprietary knowledge in the preparation of tailored amino acid-based polymers and offering use of processing facilities that will produce an innovative step…
New Corneal Transplant Technique Brings Rejection Below 1%
Corneal transplants using only the endothelial layer sharply reduce the risk of transplant rejection, according to a new comparative case series. Reuters Health Information